Search filters

Filters

Clear All

Phase

  • 67
  • 71
  • 1
  • 86
  • 1
  • 61
  • 13
  • 203
  • 578
  • 220
  • 9
  • 25
  • 548
  • 578
  • 4

Found 582 Barrett's Esophagus trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Renasight Clinical Application Review and Evaluation (RenaCARE) Study

18 years - 99 years
All genders
Interventional
The main goal of this study is to collect blood or buccal (inside the cheek) swab samples from patients with chronic kidney disease and evaluate if our test, Renasight, can help your study doctor to manage clinical care. Your study doctor will decide if your Renasight, test results will be …

Participate in a Birth Control Patch Research Study!

16 years - 35 years
Female
Phase 3
Interventional
The Women's Health Clinical Research Center at University of Pennsylvania is currently recruiting healthy women who have regular periods and do not wish to become pregnant for at least 12 months for a research study of an investigational birth control patch. The study patch that will be used in this …

A Phase 1 Multiple-Ascending-Dose Study to Assess the Safety Tolerability and Pharmacokinetics of BIIB105 Administered Intrathecally to Adults With Amyotrophic Lateral Sclerosis With or Without Poly-CAG Expansion in the Ataxin-2 Gene

All genders
This is a first in human, phase 1 trial of BIIB105, which is a novel ASO, in patients with Amyotrophic lateral sclerosis (ALS) and ALS associated with ataxin-2 (ATXN2) poly-CAG expansion (polyQ-ALS). BIIB105 will be administered via fluoro-guided LP up to 5 times over approximately 3 months. Subjects will undergo …

A Phase 2 Open-label Study to Evaluate the Safety and Efficacy of VGT-309 a Tumor-Targeted Activatable Fluorescent Imaging Agent to Identify Cancer in Subjects Undergoing Lung Cancer Surgery

All genders
Phase 2
To evaluate the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of VGT-309 to detect cancer utilizing near-infrared (NIR) fluorescence and histopathology results. 1. Sensitivity: defined as the probability that the tissue fluoresces when it is cancer, as confirmed by histology (TP/(TP+FN)) 2. Specificity: defined as the …

Study of Immune Response in Lymph Nodes and Blood following COVID Vaccination or Infection

18 years - 80 years
All genders
Observational
The research study is being conducted to study the Immune System, specifically, the immune reactions that take place in lymph nodes following either vaccination or infection. This study will be looking at vaccines and infection related to SARS-CoV-2. Procedures include: Blood draw and Fine Needle Aspiration of cervical (neck) and/or …

Assessing Drug Epetraborole in Patients with Mycobacterium avium Complex Lung Disease (MACrO2)

18 years - 99 years
All genders
Interventional
The purpose of this study is to learn about the effects of a study drug, Epetraborole, to assess the efficacy for treating refractory MAC. It will enroll patients over 18 years of age and will include the following: physical exams, CTs, medical history, ECGs, lung function tests, vital signs, safety …

ASSESSMENT OF TREATMENT WITH VISIBLE LIGHT ACTIVATED SYNTHETIC HYPERICIN OINTMENT IN MYCOSIS FUNGOIDES PATIENTS

18 years - 99 years
All genders
Phase 2
Interventional
The research study is being conducted to test the safety and efficacy of SGX301 (an investigational drug) in patients with mycosis fungoides in combination with light therapy using standard fluorescent lights. Eligible participants must have been diagnosed with mycosis fungoides, a form of Cutaneous T-cell Lymphoma. Participants will be asked …

Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy

18 years - 99 years
All genders
Phase 2
Interventional
The purpose of this study is to see if the Study drug works in the prevention of cytokine release syndrome. This is an open-label study, which means that both the participant and the study Doctor will know what study drug the participant is receiving. Participants will be in the study …

Study to Evaluate Vibegron on Patient Treatment Satisfaction Quality of Life and Healthcare Resource Utilization in Patients with Overactive Bladder

18 years - 99 years
All genders
Observational
The purpose of this study is to understand: • If you’re satisfied using GEMTESA ® (Vibegron) • What side effects (if any) you may experience using GEMTESA ® (Vibegron) • How GEMTESA ® (Vibegron) impacts your quality of life, • If you need any additional treatment for Overactive Bladder (OAB) …

Evaluate Study Drug ABBV-154 in Subjects with Moderately to Severely Active Crohn's Disease (CD): AIM-CD

18 years - 75 years
All genders
The purpose of this study is to see if the study drug ABBV-154 is safe and able to treat subjects with moderately to severely active Crohn's Disease who have an inadequate response to or were intolerant of prior biologics. ABBV-154 is an antibody-drug conjugate, which means it is composed of …
271 - 280 of 582